Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Background
Positron emission tomography/magnetic resonance imaging (PET/MRI) is a promising diagnostic imaging tool for the diagnosis of dementia, as PET can add complementary information to the routine imaging examination with MRI. The purpose of this study was to evaluate the influence of MRI-based attenuation correction (MRAC) on diagnostic assessment of dementia with [
18
F]FDG PET. Quantitative differences in both [
18
F]FDG uptake and z-scores were calculated for three clinically available (DixonNoBone, DixonBone, UTE) and two research MRAC methods (UCL, DeepUTE) compared to CT-based AC (CTAC). Furthermore, diagnoses based on visual evaluations were made by three nuclear medicine physicians and one neuroradiologist (PET
CT
, PET
DeepUTE
, PET
DixonBone
, PET
UTE
, PET
CT
+ MRI, PET
DixonBone
+ MRI). In addition, pons and cerebellum were compared as reference regions for normalization.
Results
The mean absolute difference in z-scores were smallest between MRAC and CTAC with cerebellum as reference region: 0.15 ± 0.11 σ (DeepUTE), 0.15 ± 0.12 σ (UCL), 0.23 ± 0.20 σ (DixonBone), 0.32 ± 0.28 σ (DixonNoBone), and 0.54 ± 0.40 σ (UTE). In the visual evaluation, the diagnoses agreed with PET
CT
in 74% (PET
DeepUTE
), 67% (PET
DixonBone
), and 70% (PET
UTE
) of the patients, while PET
CT
+ MRI agreed with PET
DixonBone
+ MRI in 89% of the patients.
Conclusion
The MRAC research methods performed close to that of CTAC in the quantitative evaluation of [
18
F]FDG uptake and z-scores. Among the clinically implemented MRAC methods, Dixon
Bone
should be preferred for diagnostic assessment of dementia with [
18
F]FDG PET/MRI. However, as artifacts occur in Dixon
Bone
attenuation maps, they must be visually inspected to assure proper quantification.